A pilot study of neoadjuvant combination of anti-PD-1 camrelizumab and VEGFR2 inhibitor apatinib for locally advanced resectable oral squamous cell carcinoma
Author
Abstract
Suggested Citation
DOI: 10.1038/s41467-022-33080-8
Download full text from publisher
References listed on IDEAS
- Joris L. Vos & Joris B. W. Elbers & Oscar Krijgsman & Joleen J. H. Traets & Xiaohang Qiao & Anne M. Leun & Yoni Lubeck & Iris M. Seignette & Laura A. Smit & Stefan M. Willems & Michiel W. M. Brekel & , 2021. "Neoadjuvant immunotherapy with nivolumab and ipilimumab induces major pathological responses in patients with head and neck squamous cell carcinoma," Nature Communications, Nature, vol. 12(1), pages 1-13, December.
- Lin Tian & Amit Goldstein & Hai Wang & Hin Ching Lo & Ik Sun Kim & Thomas Welte & Kuanwei Sheng & Lacey E. Dobrolecki & Xiaomei Zhang & Nagireddy Putluri & Thuy L. Phung & Sendurai A. Mani & Fabio Sto, 2017. "Mutual regulation of tumour vessel normalization and immunostimulatory reprogramming," Nature, Nature, vol. 544(7649), pages 250-254, April.
- Rebekka Duhen & Carmen Ballesteros-Merino & Alexandra K. Frye & Eric Tran & Venkatesh Rajamanickam & Shu-Ching Chang & Yoshinobu Koguchi & Carlo B. Bifulco & Brady Bernard & Rom S. Leidner & Brendan D, 2021. "Neoadjuvant anti-OX40 (MEDI6469) therapy in patients with head and neck squamous cell carcinoma activates and expands antigen-specific tumor-infiltrating T cells," Nature Communications, Nature, vol. 12(1), pages 1-14, December.
Citations
Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
Cited by:
- Li Yuan & Guo-Dong Jia & Xiao-Fei Lv & Si-Yi Xie & Shan-Shan Guo & Da-Feng Lin & Li-Ting Liu & Dong-Hua Luo & Yi-Fu Li & Shen-Wen Deng & Ling Guo & Mu-Sheng Zeng & Xiu-Yu Cai & Sai-Lan Liu & Xue-Song , 2023. "Camrelizumab combined with apatinib in patients with first-line platinum-resistant or PD-1 inhibitor resistant recurrent/metastatic nasopharyngeal carcinoma: a single-arm, phase 2 trial," Nature Communications, Nature, vol. 14(1), pages 1-17, December.
Most related items
These are the items that most often cite the same works as this one and are cited by the same works as this one.- Hongwei Lv & Qianni Zong & Cian Chen & Guishuai Lv & Wei Xiang & Fuxue Xing & Guoqing Jiang & Bing Yan & Xiaoyan Sun & Yue Ma & Liang Wang & Zixin Wu & Xiuliang Cui & Hongyang Wang & Wen Yang, 2024. "TET2-mediated tumor cGAS triggers endothelial STING activation to regulate vasculature remodeling and anti-tumor immunity in liver cancer," Nature Communications, Nature, vol. 15(1), pages 1-21, December.
- Di Wu & Yong Li & Pengfei Xu & Qi Fang & Fei Cao & Hongsheng Lin & Yin Li & Yong Su & Lixia Lu & Lei Chen & Yizhuo Li & Zheng zhao & Xiaoyu Hong & Guohong Li & Yaru Tian & Jinyun Sun & Honghong Yan & , 2024. "Neoadjuvant chemo-immunotherapy with camrelizumab plus nab-paclitaxel and cisplatin in resectable locally advanced squamous cell carcinoma of the head and neck: a pilot phase II trial," Nature Communications, Nature, vol. 15(1), pages 1-14, December.
- Huan Chen & Ting Li & Zhiyong Liu & Shuwan Tang & Jintao Tong & Yingfang Tao & Zinan Zhao & Nan Li & Chun Mao & Jian Shen & Mimi Wan, 2023. "A nitric-oxide driven chemotactic nanomotor for enhanced immunotherapy of glioblastoma," Nature Communications, Nature, vol. 14(1), pages 1-21, December.
- Alberto Gil-Jimenez & Nick Dijk & Joris L. Vos & Yoni Lubeck & Maurits L. Montfoort & Dennis Peters & Erik Hooijberg & Annegien Broeks & Charlotte L. Zuur & Bas W. G. Rhijn & Daniel J. Vis & Michiel S, 2024. "Spatial relationships in the urothelial and head and neck tumor microenvironment predict response to combination immune checkpoint inhibitors," Nature Communications, Nature, vol. 15(1), pages 1-15, December.
- Laurel B. Darragh & Jacob Gadwa & Tiffany T. Pham & Benjamin Court & Brooke Neupert & Nicholas A. Olimpo & Khoa Nguyen & Diemmy Nguyen & Michael W. Knitz & Maureen Hoen & Sophia Corbo & Molishree Josh, 2022. "Elective nodal irradiation mitigates local and systemic immunity generated by combination radiation and immunotherapy in head and neck tumors," Nature Communications, Nature, vol. 13(1), pages 1-18, December.
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:13:y:2022:i:1:d:10.1038_s41467-022-33080-8. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through the various RePEc services.